Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010

Eurosurveillance

Volumn 16, Issue 14, 2011, Pages

  Ison, C A ^a   Hussey, J ^b   Sankar, K N ^c   Evans, J ^d   Alexander, S ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Carlton Street Clinic   (United Kingdom)

^c New Croft Centre   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; PENICILLIN G; SPECTINOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CHLAMYDIAL URETHRITIS; CLINICAL FEATURE; DRUG TREATMENT FAILURE; DYSURIA; EPSILOMETER TEST; FEMALE; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; MALE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; SINGLE DRUG DOSE; TREATMENT DURATION; UNITED KINGDOM; URETHRA DISEASE;

EID: 79955441458     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. British Association for Sexual Health and HIV (BASHH). National guideline on the diagnosis and treatment of gonorrhoea in adults 2005. London: BASHH. [Accessed 24 Dec 2010]. Available from: http://www.bashh.org/documents/116/116.pdf
2. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010;15(47):pii=19721. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19721
3. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011;16(6):pii=19792. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19792
4. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004;189(8):1497-505.
5. Ochiai S, Ishiko H, Yasuda M, Deguchi T. Rapid detection of the mosaic structure of the Neisseria gnorrhoeae penA gene, which is associated with decreased susceptibilities to oral cephalosporins. J Clin Microbiol. 2008;46(5):1804-10.
6. Tapsall JW, Ndowa F, Lewis DA, Unemo M. Meeting the public health challenge of multidrug- and extensively drug- resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7(7):821-34.
7. Forsyth S, Rooney G. Cefixime resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations. Int J STD AIDS. Forthcoming 2011.
8. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. version 1.3, January 5, 2011. [Acessed 6 April 2011]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_ breakpoints_v1.3_pdf.pdf
9. Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother. 2010;65(10):2141-8.
10. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother. 2010;54(9):3812-6.